Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants

The present invention provides parenteral adjuvants comprising detoxified mutants of bacterial ADP-ribosylating toxins, particularly those from pertussis (PT), cholera (CT), and heat-labile E. coli (LT).